Anticancer agents frontiers in cancer chemotherapy
Uloženo v:
Další autoři: | |
---|---|
Korporace: | |
Médium: | E-kniha |
Jazyk: | angličtina |
Vydáno: |
Washington, DC :
American Chemical Society,
2001
|
Edice: | ACS symposium series ;
796 |
Žánr/forma: | elektronické knihy |
ISBN: | 9780841218772 (ebook) 0841218773 (ebook) 084123745X 9780841237452 |
Témata: | |
On-line přístup: | Získat plný text [Restricted access] |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|
Obsah:
- Cancer drug discovery and development : new paradigms for a new millennium / E.A. Sausville ... [et al.]
- Evolutionary biosynthesis of anticancer drugs / George R. Pettit
- Some recent developments in the synthesis and structure-activity relationship of novel taxanes / John F. Kadow ... [et al.]
- New generation taxoids and hybrids of microtubule-stabilizing anticancer agents / Iwao Ojima ... [et al.]
- Discodermolide and taxol : a synergistic drug combination in human carcinoma cell lines / Susan Band Horwitz ... [et al.]
- Highly efficient semisynthesis of biologically active epothilone derivatives / Gregory D. Vite ... [et al.]
- Synthetic and semisynthetic analogs of epothilones : chemistry and biological activity / Karl-Heinz Altmann ... [et al.]
- Synthesis and biological activity of epothilones / Ulrich Klar ... [et al.]
- Epothilones and sarcodictyins : from combinatorial libraries to designed analogs / Nicolas Winssinger and K.C. Nicolaou
- Synthesis and structure-activity relationship studies of cryptophycins : a novel class of potent antimitotic antitumor depsipeptides / Chuan Shih ... [et al.]
- Farnesyltransferase inhibitors as potential anticancer agents / J.B. Gibbs ... [et al.]
- Farnesyltransferase inhibitors : from squalene synthase inhibitors to the clinical agent BMS-214662 / John T. Hunt
- Inhibiting farnesyl protein transferase with Sch-66336 : potentially a selective noncytotoxic therapy for human cancer / A.G. Taveras ... [et al.]
- Pyrrolo[2,3-d]pyrimidine and pyrazolo[3,4-d]pyrimidine derivatives as selective inhibitors of the EGF receptor tryosine kinase / G. Caravatti ... [et al.]
- STI571 : a new treatment modality for CML? / J{uml}urg Zimmermann, Pascal Furet, and Elisabeth Buchdunger
- The discovery and development of second-generation matrix metalloproteinase inhibitors for the treatment of cancer / Andy Baxter and John Montana
- -
- Prospects for antiangiogenic therapies based upon VEGF inhibition / Pascal Furet and Paul W. Manley
- Carbohydrate-based tumor antigens as antitumor vaccine agents / Jennifer R. Allen and Samuel J. Danishefsky
- Drugs to enhance the therapeutic potency of anticancer antibodies : antibody-drug conjugates as tumor-activated prodrugs / Walter A. Bl{uml}attler and Ravi V.J. Chari.